S. 3598 directs the federal government to establish ongoing clinical guidance for treating health effects caused by PFAS (per- and polyfluoroalkyl substances), chemicals found in many consumer products and contaminated water supplies. The bill requires the Agency for Toxic Substances and Disease Registry to contract with the National Academies of Sciences, Engineering, and Medicine to conduct initial health assessments within two years and then update them every five years—or more frequently if scientific evidence warrants it. The resulting clinical guidance must be shared with doctors, state and local health officials, and the public through the agency's website. The bill also ensures that communities affected by PFAS exposure have a voice in the process by requiring the National Academies to consult with exposed populations about their experiences. The Director must finalize the initial agreement within 60 days of the bill's enactment and complete the first round of guidance within five years.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.